Letter abstract
Nature Cell Biology 8, 1017 - 1024 (2006)
Published online: 20 August 2006 | doi:10.1038/ncb1464
There is an Erratum (October 2006) associated with this Letter.
Leukaemic transformation by CALM–AF10 involves upregulation of Hoxa5 by hDOT1L
Yuki Okada1,2, Qi Jiang2,3, Margot Lemieux4, Lucie Jeannotte4, Lishan Su2,3 & Yi Zhang1,2,5
Chromosomal translocation is a common cause of leukaemia1 and the most common chromosome translocations found in leukaemia patients involve the mixed lineage leukaemia (MLL) gene2, 3. AF10 is one of more than 30 MLL fusion partners in leukaemia4. We have recently demonstrated that the H3K79 methyltransferase hDOT1L contributes to MLL–AF10-mediated leukaemogenesis through its interaction with AF10 (ref. 5). In addition to MLL, AF10 has also been reported to fuse to CALM (clathrin-assembly protein-like lymphoid–myeloid) in patients with T-cell acute lymphoblastic leukaemia (T-ALL) and acute myeloid leukaemia (AML)6, 7. Here, we analysed the molecular mechanism of leukaemogenesis by CALM–AF10. We demonstrate that CALM–AF10 fusion is both necessary and sufficient for leukaemic transformation. Additionally, we provide evidence that hDOT1L has an important role in the transformation process. hDOT1L contributes to CALM–AF10-mediated leukaemic transformation by preventing nuclear export of CALM–AF10 and by upregulating the Hoxa5 gene through H3K79 methylation. Thus, our study establishes CALM–AF10 fusion as a cause of leukaemia and reveals that mistargeting of hDOT1L and upregulation of Hoxa5 through H3K79 methylation is the underlying mechanism behind leukaemia caused by CALM–AF10 fusion.
- Department of Biochemistry & Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599–7295, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599–7295, USA.
- Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599–7295, USA.
- Centre de Recherche de L'Hotel-Dieu de Quebec, 9 rue McMahon, Quebec, QC G1R 2J6, Canada.
- Howard Hughes Medical Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599–7295, USA.
Correspondence to: Yi Zhang1,2,5 e-mail: yi_zhang@med.unc.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapyNature Article (30 Oct 2008)
NUP98?NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesisNature Cell Biology Letter (01 Jul 2007)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL????AF9Nature Letters to Editor (17 Aug 2006)
MLL?ENL cooperates with SCF to transform primary avian multipotent cellsThe EMBO Journal Article (15 Aug 2002)
See all 23 matches for Research
